Contact facts
Contract awards and IDVs
35
33 awards, 2 IDVs, as contracting staff
First SAM.gov record
Aug 4, 2024
Awards come from FPDS, which names the staff who created, approved or last changed an award without
saying which.
FPDS publishes their email address only; the name is the one it spells.
Contract awards and IDVs
Award
Awarded
Obligated
Venatorx pharmaceuticals: new antibiotics to treat drug-resistant gram-negative bacteria including public health…
75A50123C00050 · Basilea Pharmaceutica International Ltd, Allschwil
Sep 15, 2023
$45,192,122
Advance the development of SCY-247, a novel antifungal currently in phase 1 clinical trials, for the treatment of…
75A50126C00007 · Scynexis Inc.
Sep 15, 2026
$18,454,788
Advanced research and development and delivery of adult and pediatric midazolam autoinjectors that have received…
75A50122C00031 · Crossject SA
Jun 22, 2022
$108,841,769
Procurement of therapeutics for ebola, sudan and marburg viruses
75A50122C00061 · Mapp Biopharmaceutical, Inc.
Sep 30, 2022
$220,916,162
Advance the development of two antibiotics for use in the pediatric population for the treatment of serious bacterial…
75A50123C00022 · Melinta Therapeutics, LLC
Jul 6, 2023
$47,521,248
The overall objective of this contract is to demonstrate the versatility and efficacy of our programmable antiviral…
75A50124C00052 · 4J Therapeutics Inc.
Sep 30, 2024
$63,083,814
Advance the development of a medical countermeasure (MCM) evaluation platform that consists of vascular-immune and…
75A50123C00042 · The Charles Stark Draper Laboratory, Inc.
Sep 29, 2023
$45,863,892
The overall objective of this contract is to advance the development of the frontlineodp(TM) system for producing a…
75A50121C00059 · Velico Medical, Inc.
Aug 2, 2021
$139,001,591
Procurement and late-stage development of smallpox antiviral drug(S)
75A50118C00019 · Siga Technologies, Inc.
Sep 10, 2018
$626,506,870
Modeling pulmonary chlorine gas toxicity
75A50119C00058 · Wake Forest University Health Sciences
Sep 25, 2019
$31,304,179
Ebola hospital reimbursement contract
HHSO100201500003A · Varetis, Inc.
Mar 16, 2015
$3,678,368
Chimerix INC: AR & D for smallpox antiviral
75A50122C00047 · Emergent Biodefense Operations Lansing LLC
Aug 29, 2022
$213,770,068
CMC efforts for MAB114 for the development and treatment of ebola.
75A50120C00009 · Ridgeback Biotherapeutics LP
Mar 19, 2020
$19,311,430
Chimerix INC base year funding can 1992002
HHSO100201100013C · Chimerix, Inc.
Feb 16, 2011
$77,076,622
Enalare therapeutics: an agnostic respiratory stimulant for use as a medical countermeasure to treat respiratory…
75A50122C00072 · Enalare Therapeutics Inc.
Sep 22, 2022
$12,209,278
The purpose of this modification is to deobligate canceling year funds from requisition OS252049 in the amount of…
75A50118C00013 · Selux Diagnostics, Inc.
Sep 24, 2018
$62,626,467
Venatorx pharmaceuticals: antibiotic for AMR and biothreat pathogens
75A50122C00080 · Venatorx Pharmaceuticals Inc.
Sep 27, 2022
$72,141,707
Develop a next-generation, mucosally delivered, covid-19 booster vaccine capable of eliciting mucosal immunity and…
75A50123C00065 · Castlevax Inc.
Sep 30, 2023
$8,294,985
Professional technical and medical staffing support services for aspr/barda.
75A50525F65014 · Cyberpro JV LLC
Jan 15, 2025
$4,698,941
Barda professional technical and medical staffing support services
75A50524F65001 · Bryce Space And Technology, LLC
Nov 12, 2024
$2,081,737
Professional staffing support services for the office of the head of contracting activity, division of acquisition…
75A50524F65002 · Scitech Services Inc.
Jul 24, 2024
$90,000
Development of a pan-botulinum neurotoxin medical countermeasure
75A50120C00198 · Mapp Biopharmaceutical, Inc.
Sep 30, 2020
$16,413,163
Medical countermeasures (MCM) that can be deployed in the event of a filovirus outbreak are a crucial component to…
75A50123C00037 · Emergent Product Development Gaithersburg Inc.
Jul 31, 2023
$118,563,679
The overall objective of this contract is to prove a methodology to measure dose in a phantom such that there will be…
75A50125C00009 · University Of Wisconsin System
Sep 30, 2025
$449,084
Advanced research and development of rvsv-marv vaccine.
75A50119C00022 · Public Health Vaccines LLC
Feb 1, 2019
$89,026,883
Top vendors
Award value adds up the base and exercised options recorded for the contract awards naming
them. IDVs carry no value of their own.
Quick answers
Who is Audrey Glover?
Audrey Glover is a federal contracting contact at Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services). Contracting staff on 33 contract awards and 2 IDVs, from August 4, 2024 to September 25, 2026.
How do I contact Audrey Glover?
FPDS lists Audrey Glover's email audrey_glover@hhs.gov.
Which vendors has Audrey Glover awarded contracts to?
The vendors on the most contract awards and IDVs naming Audrey Glover are Venatorx Pharmaceuticals Inc., Basilea Pharmaceutica International Ltd, Allschwil and Mapp Biopharmaceutical, Inc.. Audrey Glover's contract awards to Venatorx Pharmaceuticals Inc. add up to $204M in base and exercised options.
On GovTribe
See Audrey Glover's full record
Every notice, award and file that names them
Their buying profile: what they buy and from whom
Export contacts at this office
Ask GovTribe AI about this contact
Government buyer contacts on GovTribe
Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services